TSC2 and lymphangioleiomyomatosis: Goncharova et al [21] have developed a mouse LAM model which recapitulates many of the features of LAM in humans, including nodules of TSC-2 null cells in the lungs, enlargement of alveolar airspaces and destruction of lung parenchyma.